Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...

By Yahoo! Finance   |   1 month ago
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...

The chemo mouthpiece is being introduced to the market, awaiting study results and integration into commercial contracts. Tissue Health Plus pilot launch success will be measured by system integration and improved documentation quality.

Read More

Did you find this insightful?